Olfaction: New understandings, diagnostic applications

Consultant Pharmacist

Volumn 31, Issue 11, 2016, Pages 624-632

  Ruggiero, Gabrielle F ^a   Wick, Jeannette Y ^b  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Aging; Noninvasive diagnostics; Odor identification; Olfaction; Smell

Indexed keywords

AGE; ANOSMIA; ARTICLE; DYSOSMIA; EARLY DIAGNOSIS; GENDER; HIPPOCAMPUS; HUMAN; HYPOSMIA; ODOR; OLFACTORY BULB; OLFACTORY HALLUCINATION; PAROSMIA; PREDICTION; SMELLING; SMELLING DISORDER; AGED; DRUG EFFECTS; FEMALE; MALE; METABOLISM; MIDDLE AGED; OLFACTORY RECEPTOR NEURON; PATHOPHYSIOLOGY; QUALITY OF LIFE; RISK FACTOR; SEX FACTOR; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OLFACTION DISORDERS; OLFACTORY BULB; OLFACTORY PERCEPTION; OLFACTORY RECEPTOR NEURONS; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; SIGNAL TRANSDUCTION; SMELL;

EID: 84994680459     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2016.624     Document Type: Article

References (69)

1. McCann Worldgroup. The Truth About Youth. Scribd Web site. Available at http://www.scribd.com/doc/56263899/McCannWorldgroup-Truth-About-Youth. May 25, 2011. Accessed February 3, 2016.
2. Hoffman HJ, Ishii EK, Macturk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Ann N Y Acad Sci 1998; 855:716-22.
3. Murphy C, Schubert CR, Cruickshanks KJ et al. Prevalence of olfactory impairment in older adults. JAMA 2002; 288:2307-12.
4. Leopold D. Distortion of olfactory perception: diagnosis and treatment. Chem Senses 2002; 27:611-5.
5. Pinto JM Olfaction. Proc Am Thorac Soc 2011; 8:46-52.
6. Ackerman BH, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy 1997; 17:482-96.
7. Graziadei PC Cell dynamics in the olfactory mucosa. Tissue Cell 1973; 5:113-31.
8. Loo AT, Youngentob SL, Kent PF et al. The aging olfactory epithelium: neurogenesis, response to damage, and odorant-induced activity. Int J Dev Neurosci 1996; 14:881-900.
9. Wolters E, Braak H. Parkinson's disease: premotor clinicopathological correlations. J Neural Transm Suppl 2006; 70:309-19.
10. Wilson RS, Arnold SE, Schneider JA et al. The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry 2007; 78:30-5.
11. Arendt T, Bigl V, Arendt A et al. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol 1983; 61:101-8.
12. Nakano I, Hirano A. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 1984; 15:415-8.
13. Fletcher ML, Wilson DA. Experience modifies olfactory acuity: acetylcholine-dependent learning decreases behavioral generalization between similar odorants. J Neurosci 2002; 22:RC201.
14. Doty RL, Bagla R, Kim N. Physostigmine enhances performance on an odor mixture discrimination test. Physiol Behav 1999; 65:801-4.
15. Kopala LC, Good K P, Morrison K et al. Impaired olfactory identification in relatives of patients with familial schizophrenia. Am J Psychiatry 2001; 158:1286-90.
16. Doty RL, Li C, Mannon LJ et al. Olfactory dysfunction in multiple sclerosis. N Engl J Med 1997; 336:1918-9.
17. Kohler CG, Moberg PJ, Gur RE et al. Olfactory dysfunction in schizophrenia and temporal lobe epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14:83-8.
18. Doty RL, Yousem DM, Pham LT et al. Olfactory dysfunction in patients with head trauma. Arch Neurol 1997; 54:1131-40.
19. Malkarnekar NA, Behere RV, Bhandary RP et al. Olfactory perceptual abnormality associated with vitamin B12 deficiency. Psychosomatics 2014; 55:310-1.
20. Mackay-Sim A, Dreosti IE. Olfactory function in zinc-deficient adult mice. Exp Brain Res 1989; 76:207-12.
21. Vent J, Robinson AM, Gentry-Nielsen MJ et al. Pathology of the olfactory epithelium: smoking and ethanol exposure. Laryngoscope 2004; 114:1383-8.
22. Apter AJ, Mott AE, Frank ME et al. Allergic rhinitis and olfactory loss. Ann Allergy Asthma Immunol 1995; 75:311-6.
23. Kern RC Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laryngoscope 2000; 110:1071-7.
24. Sugiura M, Aiba T, Mori J et al. An epidemiological study of postviral olfactory disorder. Acta Otolaryngol Suppl 1998; 538:191-6.
25. Hummel T, Sekinger B, Wolf SR et al. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997; 22:39-52.
26. Doty RL, Shaman P, Kimmelman CP et al. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984; 94:176-8.
27. Gibberd FB, Feher MD, Sidey MC et al. Smell testing: an additional tool for identification of adult Refsum's disease. J Neurol Neurosurg Psychiatry 2004; 75:1334-6.
28. Goudsmit N, Coleman E, Seckinger RA et al. A brief smell identification test discriminates between deficit and non-deficit schizophrenia. Psychiatry Res 2003; 120:155-64.
29. Menon C, Westervelt HJ, Jahn DR et al. Normative performance on the Brief Smell Identification Test (BSI) in a multi-ethnic bilingual cohort: a Project FRONTIER study. Clin Neuropsychol 2013; 27:946-61.
30. Doty RL, Marcus A, Lee W W. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996; 106:353-6.
31. Morgan CD, Murphy C. Olfactory event-related potentials in Alzheimer's disease. J Int Neuropsychol Soc 2002; 8:753-63.
32. Temmel AF, Quint C, Schickinger-Fischer B et al. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002; 128:635-41.
33. Devanand DP, Lee S, Manly J et al. Olfactory identification deficits and increased mortality in the community. Ann Neurol 2015; 78:401-11.
34. Santos D V, Reiter ER, DiNardo LJ et al. Hazardous events associated with impaired olfactory function. Arch Otolaryngol Head Neck Surg 2004; 130:317-9.
35. Ferris AM, Duffy VB. Effect of olfactory deficits on nutritional status. Does age predict persons at risk? Ann N Y Acad Sci 1989; 561:113-23.
36. Neuland C, Bitter T, Marschner H et al. Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia. Laryngoscope 2011; 121:867-72.
37. Roberts RO, Christianson TJ, Kremers WK et al. Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurol 2016; 73:93-101.
38. Yoon JH, Kim M, Moon SY et al. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: a 5-year follow-up study. J Neurol Sci 2015; 355:174-9.
39. Huart C, Rombaux P, Gérard T et al. Unirhinal olfactory testing for the diagnostic workup of mild cognitive impairment. J Alzheimers Dis 2015; 47:253-70.
40. Pelton GH, Soleimani L, Roose SP et al. Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: a randomized controlled pilot study. Alzheimer Dis Assoc Disord 2015 [Epub ahead of print].
41. Henkin RI Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994; 11:318-77.
42. Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Hudson, OH: Wolters Kluwer Health, Inc. Available at http://online.lexi.com. Accessed February 20, 2016.
43. FDA Advises Consumers Not to Use Certain Zicam Cold Remedies: Intranasal Zinc Product Linked to Loss of Sense of Smell. June 16, 2009. U.S. Food and Drug Administration Web site. Available at http://www.fda.gov/Newsevents/Newsroom/PressAnnouncements/ucm167065.htm. Accessed February 3, 2016.
44. Alexander TH, Davidson TM. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope 2006; 116:217-20.
45. Abu-Hamdan DK, Desai H, Sondheimer J et al. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1988; 1:303-8.
46. Neil-Dwyer G, Marus A. ACE inhibitors in hypertension: assessment of taste and smell function in clinical trials. J Hum Hypertens 1989; 3:169-76.
47. Micromedex 2.0 Truven Health Analytics, Inc. Greenwood Village, CO.: Truven Health Analytics, Inc. Available at http://micromedexsolutions.com. Accessed February 20, 2016.
48. Konstantinidis I, Tsakiropoulou E, Iakovou I et al. Anosmia after general anaesthesia: a case report. Anaesthesia 2009; 64:1367-70.
49. Dhanani NM, Jiang Y. Anosmia and hypogeusia as a complication of general anesthesia. J Clin Anesh 2012; 24:231-1.
50. Whittet HB, Shinkwin C, Freeland A P. Anosmia due to nasal administration of corticosteroid. Br Med J 1991; 303:651.
51. Norvasc® [package insert]. New York, NY: Pfizer Labs; 2011.
52. Berman JL Dysosmia, dysgeusia, and diltiazem. Ann Intern Med 1985; 102:717.
53. Levenson JL, Kennedy K. Dysosmia dysgeusia, and nifedipine. Ann Intern Med 1985; 102:135-6.
54. Zufall F, Firestein S. Divalent cations block the cyclic nucleotide-gated channel of olfactory receptor neurons. J Neurophysiol 1993; 69:1758-68.
55. Kharoubi S. Drug induced anosmia with nifedipine. Presse Med 2003; 32:1269-72.
56. Flötra L, Gjermo P, Rölla G et al. Side effects of chlorhexidine mouth washes. Scand J Dent Res 1971; 79:119-25.
57. Hoffman DL, Howard JR Jr, Sarma R et al. Encephalopathy, myelopathy, optic neuropathy, and anosmia associated with intravenous cytosine arabinoside. Clin Neuropharmacol 1993; 16:258-62.
58. Bleasel AF, McLeod JG, Lane-Brown M. Anosmia after doxycycline use. Med J Aust 1990; 152:440.
59. Keiser HR, Henkin RI, Bartter FC et al. Loss of taste during therapy with penicillamine. JAMA 1968; 203:381-3.
60. Weber JC, Alt M, Blaison G et al. Changes in taste and smell caused by hydroxychloroquine. Presse Med 1996; 25:213.
61. Cocquyt VF, Van Belle SJ Anosmia associated with alphainterferon treatment. Ann Oncol 1994; 5:863.
62. Maruyama S, Hirayama C, Kadowaki Y et al. Interferon-induced anosmia in a patient with chronic hepatitis C. Am J Gastroenterol 1998; 93:122-3.
63. Pinals RS The non-hematological side effects of levamisole in the treatment of rheumatoid arthritis - review. J Rheumatol Suppl 1978; 4:71-5.
64. Vital Durand M. Recurrent anosmia under beta-blockers. Presse Med 1985; 14:2064.
65. Grossman S. Loss of taste and smell due to propylthiouracil therapy. N Y State J Med 1953; 53:1236.
66. Beutler M, Hartmann K, Kuhn M et al. Taste disorders and terbinafine. Br Med J 1993; 307:26.
67. Villota Hoyos R, Gonzalez-Ruiz M. Terbinafine-induced ageusia and hyposmia. Aten Primaria 1999; 23:102-3.
68. Roche Pharmaceuticals. Vesanoid complete prescribing information. Nutley, NJ: Roche Pharmaceuticals; 2004.
69. King Pharmaceuticals. Sonata complete prescribing information. Bristol, TN: King Pharmacueticals; 2003.